SCHEMBL5515728

SCHEMBL5515728

COc1cc(OC)c(Cc2ccccc2N)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.46
▸ ADRA2B P18089 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ CYP3A4 P08684 1/20 0.44
▸ CALM1 P0DP23 1/20 0.42
▸ PTPN1 P18031 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ GAA P10253 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ IDO1 P14902 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8504988 0.80 ALDH1A1 (0.45) ALDH1A1TDP1CYP3A4MAPTMEN1
SCHEMBL10388544 0.77 ALDH1A1 (0.59) ALDH1A1ADRA2BPTGS1TDP1MAPT
SCHEMBL6069500 0.77 ALDH1A1 (0.46) ALDH1A1ADRA2BPTGS1TDP1CYP3A4
SCHEMBL2096172 0.75 ALDH1A1 (0.50) ALDH1A1CYP3A4CALM1PTPN1MAPT
SCHEMBL18029929 0.75 LTA4H (0.57) ALDH1A1CYP3A4PTPN1TSHRMAPK1
SCHEMBL27762002 0.74 ALDH1A1 (0.43) ALDH1A1ADRA2BPTGS1TDP1MAPT
SCHEMBL6160843 0.74 LTA4H (0.60) ALDH1A1TDP1MAPTMEN1KMT2A
SCHEMBL11037471 0.72 KDM1A (0.43) ALDH1A1TDP1CYP3A4MAPTMEN1
SCHEMBL21154654 0.72 NPC1 (0.48) CALM1PTPN1MAPTMEN1KMT2A
SCHEMBL11198592 0.71 GAA (0.53) ALDH1A1TDP1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250444-B2 Pyrrole-based HMG-CoA reductase inhibitors PFIZER INC. (US) 2007-07-31 — — US disclosed
US-20060287378-A1 Novel pyrroles and imidazoles WARNER-LAMBERT COMPANY LLC 2006-12-21 — — US disclosed
EP-1656132-A2 NOVEL PYRROLE-BASED HMG-COA REDUCTASE INHIBITORS Warner-Lambert Company LLC (US) 2006-05-17 — — EP disclosed
US-20050043364-A1 Novel pyrrole-based HMG-CoA reductase inhibitors KENNEDY ROBERT MICHAEL (US) 2005-02-24 — — US disclosed
WO-2005014539-A2 PYRROLE-BASED HMG-COA REDUCTASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-02-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043364-A1 Novel pyrrole-based HMG-CoA reductase inhibitors HMGCR, DHCR7, HSD17B12 ALDH1A1 1460/4885ADRA2B 3206/4885PTGS1 219/4885
US-20060287378-A1 Novel pyrroles and imidazoles PPIP5K2, PPIE, PPOX ALDH1A1 2496/4885ADRA2B 2791/4885PTGS1 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback